Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Neo Kuma Ventures
AddedFeb 15, 2024
UpdatedJun 28, 2026
Neo Kuma Ventures

Neo Kuma Ventures

Operating

Europe's pioneering psychedelic healthcare investment fund with a robust portfolio.

Location
London, Greater London, GB
Founded
2020
Firm
Compare
Portfolio
Employees
Website

Neo Kuma Ventures is Europe's pioneering venture capital firm dedicated exclusively to psychedelic healthcare investments. The firm focuses on early-stage companies that are at the forefront of clinical research in psychedelic therapies, aiming to redefine patient care standards. Neo Kuma Ventures typically invests in Seed and Series A rounds, supporting companies that are developing breakthrough treatments for mental health conditions.

Notable portfolio companies include Fluence, Journey Clinical, and Tripp, which have collectively raised significant funding to advance their innovative therapies. Key partners at Neo Kuma Ventures bring extensive expertise in both venture capital and the healthcare sector, ensuring strategic guidance and support for their portfolio companies. The firm’s investment philosophy centers on empowering the use of psychedelic therapies to address the root causes of mental illness, offering unique value-add services such as industry connections and specialized knowledge in psychedelic healthcare.

Neo Kuma Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments3
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Seed2 (66.7%)
Series A1 (33.3%)

Stage Mix

Seed 67%Series A 33%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Fluence logo

Fluence

Journey Clinical logo

Journey Clinical

Tripp logo

Tripp

Neo Kuma Ventures - Similar Investment Firms

Neo Ventures logo

Neo Ventures

Iter Investments logo

Iter Investments

PsyMed Ventures logo

PsyMed Ventures

psymed.ventures

Empath Ventures logo

Empath Ventures

empath.vc

Neu Venture Capital logo

Neu Venture Capital

neuvc.com

Purple Ventures logo

Purple Ventures

Neotribe Ventures logo

Neotribe Ventures

neotribe.vc

NeuroVentures Capital logo

NeuroVentures Capital

neuroventures.com

NEO Investment Partners logo

NEO Investment Partners

Vine Ventures logo

Vine Ventures

vineventures.com

Moonfire Ventures logo

Moonfire Ventures

moonfire.com

Mystic Ventures logo

Mystic Ventures

NextGen Ventures logo

NextGen Ventures

nextgenventures.nl

Leafy Tunnel logo

Leafy Tunnel

leafytunnel.com

Neoko Capital logo

Neoko Capital

neokocapital.com

Neo Kuma Ventures - Classification

Also Known As
  • Neo Kuma Venture Partners LLP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end